NO2006013I2 - Humant parathyreoidahormon (Humant parathyroid hormon) - Google Patents

Humant parathyreoidahormon (Humant parathyroid hormon)

Info

Publication number
NO2006013I2
NO2006013I2 NO2006013C NO2006013C NO2006013I2 NO 2006013 I2 NO2006013 I2 NO 2006013I2 NO 2006013 C NO2006013 C NO 2006013C NO 2006013 C NO2006013 C NO 2006013C NO 2006013 I2 NO2006013 I2 NO 2006013I2
Authority
NO
Norway
Prior art keywords
parathyroid hormone
human parathyroid
human
ultrapure
hormone
Prior art date
Application number
NO2006013C
Other languages
English (en)
Other versions
NO2006013I1 (no
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2006013(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Publication of NO2006013I1 publication Critical patent/NO2006013I1/no
Publication of NO2006013I2 publication Critical patent/NO2006013I2/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO2006013C 1991-05-23 2006-10-24 Humant parathyreoidahormon (Humant parathyroid hormon) NO2006013I2 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone

Publications (2)

Publication Number Publication Date
NO2006013I1 NO2006013I1 (no) 2006-11-06
NO2006013I2 true NO2006013I2 (no) 2009-12-07

Family

ID=24840399

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19922000A NO304190B1 (no) 1991-05-23 1992-05-21 Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det
NO2006013C NO2006013I2 (no) 1991-05-23 2006-10-24 Humant parathyreoidahormon (Humant parathyroid hormon)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19922000A NO304190B1 (no) 1991-05-23 1992-05-21 Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det

Country Status (15)

Country Link
US (1) US5208041A (no)
EP (1) EP0515228B1 (no)
JP (1) JP2563726B2 (no)
KR (1) KR970007755B1 (no)
AT (1) ATE164394T1 (no)
CA (1) CA2068438C (no)
DE (1) DE69224858T2 (no)
DK (1) DK0515228T3 (no)
ES (1) ES2115642T3 (no)
FI (1) FI106802B (no)
IE (1) IE921672A1 (no)
IL (3) IL101829A (no)
NO (2) NO304190B1 (no)
NZ (1) NZ242855A (no)
ZA (1) ZA923735B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
AU8002994A (en) * 1993-10-27 1995-05-22 Chugai Seiyaku Kabushiki Kaisha Cure accelerator in chondroplasty
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
ES2320603T3 (es) 1997-07-30 2009-05-25 Emory University Sistemas de expresion, vectores, adn, proteinas de mineralizacion osea novedosos.
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
JP4486256B2 (ja) * 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
WO2000032771A1 (en) 1998-11-30 2000-06-08 The General Hospital Corporation Pth1r and pth3r receptors, methods and uses thereof
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
WO2004028444A2 (en) * 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
BR0112381A (pt) 2000-06-30 2003-05-06 Suntory Ltd Componente farmacêutico com base em hormÈnio da paratireóide humana e uma composição farmacêutica para administração intranasal compreendendo o componente
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US7572765B2 (en) * 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
AU2003220380A1 (en) * 2003-03-19 2004-11-19 Bristol-Myers Squibb Company CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
EP1653985A4 (en) 2003-07-17 2009-08-05 Gen Hospital Corp FORCED PARATHORMON (PTH) ANALOGUE
MXPA06013168A (es) 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
WO2007059470A2 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
WO2008019062A2 (en) * 2006-08-04 2008-02-14 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
BRPI0814962B8 (pt) * 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
MX2010001612A (es) * 2007-08-09 2010-07-01 Usv Ltd Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34).
PL2464655T3 (pl) * 2009-08-11 2017-08-31 Biocon Limited Procesy chromatograficzne
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
CN108195965B (zh) * 2011-06-07 2021-02-23 旭化成制药株式会社 含pth肽冷冻干燥制剂的检査方法及包含该含pth肽冷冻干燥制剂的医药品的制造方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
WO2021195877A1 (en) 2020-03-30 2021-10-07 Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. Formulations of human parathyroid hormone (pth) and methods for producing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
AU6448990A (en) * 1989-09-29 1991-04-28 Her Majesty in Right of Canada, as represented by National Research Council Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
AU639856B2 (en) 1993-08-05
FI922356L (fi) 1992-11-24
AU1604992A (en) 1993-03-11
NO922000L (no) 1992-11-24
KR970007755B1 (en) 1997-05-16
IL119840A (en) 2005-08-31
JPH0687897A (ja) 1994-03-29
ZA923735B (en) 1993-01-27
JP2563726B2 (ja) 1996-12-18
DE69224858T2 (de) 1998-07-23
DK0515228T3 (da) 1998-09-28
NO2006013I1 (no) 2006-11-06
FI922356A0 (fi) 1992-05-22
CA2068438C (en) 1996-11-12
IL101829A (en) 1999-12-31
IL119840A0 (en) 1997-03-18
NO304190B1 (no) 1998-11-09
NZ242855A (en) 1994-04-27
HK1004340A1 (en) 1998-11-20
NO922000D0 (no) 1992-05-21
CA2068438A1 (en) 1992-11-24
US5208041A (en) 1993-05-04
ATE164394T1 (de) 1998-04-15
FI106802B (fi) 2001-04-12
IL101829A0 (en) 1992-12-30
EP0515228B1 (en) 1998-03-25
DE69224858D1 (de) 1998-04-30
ES2115642T3 (es) 1998-07-01
EP0515228A3 (no) 1994-05-04
EP0515228A2 (en) 1992-11-25
IE921672A1 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
NO2006013I1 (no) Humant parathyreoidahormon (humant parathyroid hormon)
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
FI881652A7 (fi) Isoelektrinen fokusointimenetelmä ja laite mainitun menetelmän suorittamiseksi
KR850004664A (ko) 자연어에 의한 지적가이던스방법(知的 guidence 方法) 및 그 장치
ATE72833T1 (de) Rinder-prowachstums- und -wachstumshormon.
DE3778438D1 (de) Referenzspannung fuer transistorkonstantstromquelle.
DE3682249D1 (de) Verfahren zur bildbearbeitung und geraet zur bilderzeugung.
NO920703D0 (no) Fusjonsproteiner som omfatter gm-csf og il-3
NO901026L (no) Anordning og fremgangsmaate for naturlig spraakanalysering.
ATE78590T1 (de) Probennehmer.
DE69127999D1 (de) Interne-Standard zur elektrophoretischen Trennung
DE3685043D1 (de) Linsenmessgeraet und messverfahren dazu fuer gleitsichtlinsen.
DE3662077D1 (de) A lorgnette frame
DE3778483D1 (de) Vorrichtung fuer linearlager mit vollstaendiger nachstellung und entsprechendes verfahren.
DE3787723D1 (de) Gerät zur kontaminationsanalyse.
GR851623B (no)
FI870285A7 (fi) Menetelmä levymäisten kappaleiden asemoimiseksi ja laite tätä varten.
DK639089A (da) Fremgangsmaade til oploeseliggoerelse og naturering af somatotropin
IT1136664B (it) Rivealtore termoionico a fiamma modificata per gas-cromatografi,e metodo di identificazione di componenti in un campione sotto analisi
FR2714768B1 (fr) Dispositif de balayage électronique à lentille active et source illuminatrice intégrée.
DE69018538D1 (de) Verfahren und Gerät zur Steuerprogrammentwicklung.
ATE12839T1 (de) Reagenz fuer die bestimmung des ristocetincofaktors (v. willibrand-faktor).
FI905985L (fi) Menetelmä somatotropiinien saamiseksi liukoisiksi ja naturoimiseksi käyttämällä alhaista urean konsentraatiota
KR880700961A (ko) 제어장치 자동 검사 방법
FR2592525B1 (fr) Procede de fabrication d'un transistor lateral integre et circuit integre le comprenant

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SHIRE-NPS PHARMACEUTICALS, US